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ABSTRACT
Purpose: Within the EU RENEB project, seven laboratories have taken part in training and harmonisa-
tion activities to strengthen triage gamma-H2AX-based radiation exposure assessment. This has culmi-
nated in a second triage biodosimetry exercise.
Materials and methods: Whole blood and separated lymphocyte samples were homogenously
irradiated with 60Co gamma rays at 0.5, 2.5 (blind samples), 0 and 2Gy (reference samples). Following
post-exposure incubations of 4 and 24h, 16 samples were shipped on ice packs to each partner. The
samples were stained and scored for gamma-H2AX foci, using manual and/or automated fluorescence
microscope scoring strategies. Dose estimates were obtained and used to assign triage categories to
the samples.
Results: Average dose estimates across all the laboratories correlated well with true doses. The most
accurate assignment of triage category was achieved by manual scoring of the 4-h blood and lympho-
cyte samples. Only three samples out of a total of 46 were miscategorized in a way that could have
adversely effected the clinical management of a radiation casualty.
Conclusions: This inter-comparison exercise has demonstrated that following a recent acute radiation
exposure, the gamma-H2AX assay could be a useful triage tool that can be successfully applied across
a network of laboratories.
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Introduction
In a mass casualty radiation incident the triage of potentially
exposed individuals is a crucial first step in the medical man-
agement of casualties. However, given the non-specific
nature of the clinical signs and symptoms used for triage, it
is important to provide confirmation of a patient’s exposure
status with the help of biological dosimetry tools (Voisin
et al. 2001). Dosimetry information can be used to separate
the ‘worried well’, who may exhibit some of the symptoms
of acute radiation syndrome due to pre-existing conditions
or stress reactions triggered by the event, from critically
exposed individuals. In a large scale event, with potentially
hundreds to thousands of casualties, a single biological dos-
imetry laboratory’s surge capacity would easily be exceeded
and therefore assistance networks have been recognized as
an important element of emergency response strategies (Roy
et al. 2007; Blakely et al. 2009). The aim of the EU RENEB
(Realizing the European Network of Biodosimetry) project
was to establish a sustainable European network for
existing laboratories and using six established biodosimetry
assays – (1) the dicentric assay; (2) the FISH-translocation
assay; (3) the micronucleus assay; (4) the premature chromo-
some condensation assay; (5) the gamma-H2AX assay; and 6)
electron paramagnetic resonance/optically stimulated lumi-
nescence. The objective of this work was to further
strengthen the basis of the assays for use in emergency scen-
arios by harmonising responses between the partners
through standardization of methods, training and inter-
comparison exercises (Kulka et al. 2012, 2015).
The gamma-H2AX foci assay is a sensitive surrogate
marker of radiation induced DNA double strand breaks
(Ivashkevich et al. 2012; Rothkamm et al. 2015) and may be a
useful early biodosimetry tool from hours to about three
days post-exposure (Roch-Lefevre et al. 2010; Horn &
Rothkamm 2011; Horn et al. 2011; Mandina et al. 2011).
Several studies have shown that rapid processing time of the
gamma-H2AX assay can produce dose estimates within a few
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hours of receiving a blood sample (Rothkamm et al. 2013a;
Ainsbury et al. 2014). In addition, the potential for batch
processing on finger prick blood samples, enabling high
throughput (Moquet et al. 2014), makes the assay ideal for
early triage categorization to separate the ‘worried well’ from
critically exposed individuals by quantifying radiation-induced
foci in peripheral blood lymphocytes. The first inter-compari-
son study of the RENEB partners was described by Barnard
et al. 2015 and showed the potential for the gamma-H2AX
assay, as a tool for rapid dose categorization in emergency
response, to be established in a functional biodosimetry net-
work within Europe.
During the first inter-comparison, isolated lymphocytes
were shipped to all participants, because of intermittent
problems with blood cell separation after prolonged incuba-
tion and storage of whole blood samples, e.g. haemolysis.
However, in a real incident, it would be very difficult to
undertake such a separation step prior to shipment of sam-
ples. For this reason, the second exercise aimed to compare
the assay performance for shipped lymphocytes with that for
whole blood as well as to further harmonise the assay
between the RENEB partners.
Materials and methods
Blood sampling, irradiation and shipment
The blood sampling and the irradiations occurred on two
consecutive days in order to allow the 24 h and 4 h ex vivo
incubated samples to be shipped to the seven participating
laboratories at the same time. Heparinised venous whole
blood was taken with written informed consent in accord-
ance with local ethics procedures from two healthy volun-
teers on day 1 and three donors on day 2. The volume of
blood required for the inter-comparison and the limits pre-
scribed for ethics approval meant that more than one blood
donor had to be used. However, each laboratory received
blood and separated lymphocytes from the same donor for a
given time-point and all doses. Two or three laboratories
received samples from the same donor. Based on previous
experience using the five donors and on published studies
(Roch-Lefevre et al. 2010; Chua et al. 2011), any variability
between the donors would be expected to make only a small
contribution to overall uncertainties.
The freshly drawn blood was separated on histopaque
1077 (Sigma-Aldrich, Dorset, UK) and the isolated lympho-
cytes suspended in Minimal Essential Medium (MEM), supple-
mented with 10% heat-inactivated foetal bovine serum (FBS),
100 units/ml penicillin plus 100 lg/ml streptomycin and
2mM L-glutamine (all from Invitrogen, Paisley, UK). In add-
ition, whole blood was diluted 1:1 with MEM in an effort to
keep the samples in good condition, as previous work during
the MULTIBIODOSE project (Rothkamm et al. 2013b) had
shown that incubating blood at 37 C, even for short periods,
to simulate in vivo repair resulted in poor sample processing
following shipment. Diluting blood would not be required in
an actual event. Irradiation of the separated lymphocytes and
diluted blood samples was performed at 37 C with a
60Co gamma source, at a dose rate of 0.67Gy/min. Doses of
0.5, 2 and 2.5 Gy were used and a zero dose control sample
was also transported to the irradiation facility for sham
exposure. Following irradiation, samples were incubated at
37 C for 4 or 24 h, to simulate in vivo repair, then cooled
to 4 C. Lymphocyte samples were spun down and resus-
pended in 100% cold FBS at approximately 0.5 x 106 cells/ml
and aliquoted into cryovials. Four ml diluted blood per dose
point per laboratory was aliquoted into FalconVR tubes. The
samples were then wrapped and shipped on frozen cold
packs, together with a temperature logger, to the participat-
ing laboratories. Reference samples of 0 and 2Gy were
included in the shipment, together with two coded samples
X and Y (0.5 and 2.5 Gy, respectively). All seven laboratories
received the 4-h ex vivo incubated blood and isolated
lymphocyte samples. Five participants volunteered to analyse
the 24-h ex vivo incubated samples.
Gamma-H2AX immunofluorescence staining and
microscope analysis
Following receipt of the samples, they were processed in
each laboratory according to the standard protocol based on
the method described in Rothkamm et al. (2013b). In brief,
the lymphocyte samples were spun down and washed in
phosphate buffered saline (PBS). The diluted whole blood
was layered onto histopaque 1077 in order to isolate the
lymphocytes. Cell suspensions were then spotted onto adhe-
sive microscope slides, fixed in formaldehyde (e.g.
Polysciences Inc. Warrington, PA), permeabilised and
extracted with Triton X (e.g. Sigma-Aldrich, Dorset, UK),
blocked with bovine serum albumin (e.g. Fisher Scientific,
Loughborough, UK) and immunostained for gamma-H2AX
using fluorophore-conjugated secondary antibodies (e.g.
AlexaFluor 488 goat anti-mouse, Invitrogen, Paisley, UK). All
participants scored foci manually (Horn et al. 2011) in a total
of 50 cells per sample and in addition three laboratories
scored a total of 200 cells per sample automatically using
Cellprofiler (www.cellprofiler.org) or MetaCyte (Metasystems,
Altlussheim, Germany; Vandersicklel et al. 2010). Also, partici-
pants used the 2Gy reference samples to test the validity of
their calibration curves and the unirradiated samples gave an
indication of the level of background staining achieved on
the day of the exercise, as suggested in Rothkamm et al.
(2013b). A standardized scoring sheet was used by the partic-
ipants to report foci numbers and dose estimates for 10, 20,
30, 40 and 50 cells scored manually or 20, 50, 100, 150 and
200 cells scored automatically. All the participants’ dose esti-
mates were returned to the coordinating laboratory for
statistical analysis.
Data analysis
Standard errors were calculated according to Poisson statis-
tics, which are assumed to dominate the random error (IAEA,
2011; Barnard et al. 2015). Foci counts were converted to
dose estimates by the participants using their own calibra-
tion curves and the software package Dose Estimate_v5.1
(Ainsbury & Lloyd 2010); although one laboratory used
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R (www.r-project.org). The calibration data were fitted to a
linear model using iteratively reweighted least squares fitting
in Dose Estimate according to standard practice (Barnard
et al. 2015). Alpha is the linear coefficient and C the intercept
of the fit. v2 testing was used to compare the observed and
expected foci yields for the reference samples. The general
linear model analysis of variance (ANOVA) and post-hoc test-
ing (Tukey’s pairwise comparisons) were performed for the
dose estimates using MinitabVR 15. The following experimental
factors were tested against the dose estimates: post-exposure
time (4 or 24h); scoring method (manual or
automatic); temperature during transit; donor nested in post-
exposure time (1–5); laboratory (1–8; omitting lab 2 as they
were unable to take part in the second exercise); number of
cells scored nested in scoring method (10–50 for manual and
50–200 for automated scoring); and sample type (whole blood
or lymphocytes). In addition, a z-score of the dose was calcu-
lated for each dose estimate in order to determine a labo-
ratory’s results as satisfactory (jzj  2), questionable (2 < jzj <
3), and unsatisfactory (jzj> 3) (Romm et al. 2014). It should be
noted that, throughout the paper, the statistical power of the
data is in some cases fairly weak due to the small numbers of
participants. However, in all cases there were sufficient labora-
tories for statistical significance of the results.
Results
Seven laboratories took part in the second inter-comparison
and for comparison the allocated laboratory number corre-
sponds to that used in the first exercise (Barnard et al. 2015).
Six participants received the samples within 23 h (range 17–
23 h), but for one laboratory (lab 8) the shipment was
delayed at the airport and arrived at the institute after about
44 h in transit. As a consequence this participant was only
able to analyse the 4-h ex vivo incubated blood and
lymphocyte samples. During shipment the temperature of
the sample containers remained between 6 and 15 C, only
rising to above 20 C on reaching the laboratory. The tem-
perature of the delayed sample only rose above 16 C to a
maximum of 19.5 C for about the last 1.5 h of transit. Each
laboratory processed samples immediately upon receipt. A
few of the laboratories had difficulty processing the diluted
whole blood samples, especially the 24 h ex vivo samples,
due to haemolysis. This made lymphocyte separation and
subsequent staining problematic or impossible.
Table 1 shows the foci yields ± Poisson standard errors
and the calibration coefficients used to convert foci counts
into dose estimates for each laboratory. All the partner labo-
ratories have appropriate calibration curves for gamma radi-
ation for 4 and 24 h incubation periods plus overnight
shipment on cold packs. Four laboratories (labs 1, 3, 5 and 6)
used calibration curves that had been produced during the
first inter-comparison (Barnard et al. 2015). Labs 4, 7 and 8
used more recently prepared curves. Three participants chose
to score foci manually as well as automatically. The data
from the reference samples were grouped into 0Gy and 2Gy
and v2 testing revealed there was no significant difference
between the observed and expected foci yields, calculated
from each laboratory’s original calibration curve, p¼ 1.0 and
0.46, respectively. At 2Gy, most of the v2 value came from just
a few of the data points and labs 6 and 8 used the 2Gy refer-
ence sample to adjust their calibration curves, before produc-
ing a dose estimate. The calibration curve produced by lab 7
used automated scoring mode; therefore the manual dose esti-
mate was also produced by adjusting the curve with the 2Gy
manually scored reference sample. Full details of the reference
sample procedure are given in Ainsbury et al. 2016.
Z-score analysis showed inter-laboratory variation across
the different samples and that most laboratories overesti-
mated the dose of the 0.5 Gy samples and underestimated
Table 1. Reported foci yields ± Poisson standard errors (SE) obtained by the laboratories using manual and automated scoring. Also shown are the constant (C)
and linear calibration coefficients (a) and associated standard errors used to convert foci counts into dose estimates.
Dose (Gy)
0.5 2.5
Blood Lymphocytes Blood Lymphocytes
Calibration coefficients ±
standard errors
foci/cell ± SE foci/cell ± SE foci/cell ± SE foci/cell ± SE C ± SE a ± SE
Cells scored manually
1-4h 1.90 ± 0.19 3.44 ± 0.26 5.20 ± 0.32 3.10 ± 0.25 0.04 ± 0.02 2.15 ± 0.09
3-4h 1.98 ± 0.20 2.20 ± 0.21 4.54 ± 0.30 4.84 ± 0.31 0.44 ± 0.16 1.90 ± 0.21
4-4h * 1.78 ± 0.19 * 6.36 ± 0.36 0.07 ± 0.02 2.24 ± 0.09
5-4h 1.82 ± 0.19 1.82 ± 0.19 3.14 ± 0.25 3.12 ± 0.25 0.10 ± 0.09 1.47 ± 0.22
6-4h 2.52 ± 0.22 3.78 ± 0.27 9.68 ± 0.44 9.64 ± 0.44 0.12 ± 0.08 3.57 ± 0.23
7-4h * 0.72 ± 0.12 * 1.86 ± 0.19 0.88 ± 0.25 1.21 ± 0.37
8-4h 1.70 ± 0.18 2.26 ± 0.21 5.70 ± 0.34 5.16 ± 0.32 0.58 ± 0.08 2.18 ± 0.17
1-24h 0.26 ± 0.07 1.46 ± 0.17 0.50 ± 0.10 2.34 ± 0.22 0.03 ± 0.04 0.79 ± 0.14
3-24h 0.40 ± 0.09 1.38 ± 0.17 0.68 ± 0.12 1.80 ± 0.19 0.28 ± 0.12 0.92 ± 0.14
4-24h * 1.12 ± 0.15 * 4.94 ± 0.31 0.06 ± 0.02 1.41 ± 0.07
6-24h * 2.12 ± 0.21 * 5.06 ± 0.33 0.09 ± 0.03 1.35 ± 0.06
Cells scored automatically
6-4h 1.84 ± 0.10 2.54 ± 0.11 3.54 ± 0.13 3.42 ± 0.13 0.45 ± 0.28 3.52 ± 0.46
7-4h * 0.67 ± 0.06 * 1.36 ± 0.08 0.88 ± 0.25 1.21 ± 0.37
8-4h 1.42 ± 0.08 1.08 ± 0.07 3.01 ± 0.12 3.66 ± 0.14 0.26 ± 0.03 1.19 ± 0.60
Samples were fixed, immunostained and scored manually and/or automatically with MetacyteVR . The yields of foci per cell ± SE (Poisson standard error) are shown
based on manual scoring of 50 cells or automated scoring of 200 cells and the calibration coefficients (± SE) used to convert foci counts into dose estimates.
*No result
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the 2.5 Gy samples. Thirteen out of the 23 dose estimates for
the 0.5 Gy samples were classed as satisfactory from
the z-score. Six were classified questionable. These were both
samples from lab 5, the lymphocyte samples from lab
6 (24 h; manual scoring) and lab 7 (4 h; manual and auto-
matic scoring) and the blood sample from lab 8 (4 h; auto-
matic scoring). Four were classed as unsatisfactory. The dose
estimates based on the lymphocyte samples for lab 1 were
both unsatisfactory (4 and 24 h; manual scoring). In addition,
dose estimates based on lymphocyte samples from lab 3
(24 h; manual scoring) and lab 6 (4 h; automated scoring)
were also unsatisfactory. However, in all cases the estimate
of dose for the corresponding whole blood samples from
these laboratories had satisfactory z-scores. Fourteen of the
23 dose estimates were satisfactory for the 2.5 Gy samples,
when the z-score was taken into account. One dose estimate
from lab 6 (blood; 4 h; automatic scoring) was classed as
questionable. Eight dose estimates were unsatisfactory. These
were the 4 h lymphocyte samples scored manually by lab 1
and 7 and the 24 h lymphocyte samples analysed by lab 3, 4
and 6. The 24 h blood samples scored manually by labs 1
and 3 produced unsatisfactory dose estimates, as well as the
4 h lymphocyte samples scored automatically by lab 7. There
are additional, alternative, methods such as precision analysis
that could be applied to assess the accuracy of results.
However, as the z-test is recommended to be applied by the
appropriate ISO standards for rapid biodosimetry categoriza-
tion (ISO 5725-5:1998 and ISO 13528:2015) and moreover,
the classification technique applied here (satisfactory, ques-
tionable or unsatisfactory) is also becoming the standard in
biodosimetry and has been applied in many previous inter-
comparisons, the z-test has been judged to be the most
appropriate method to compare the results.
General linear model ANOVA was carried out on the data
set in order to investigate the contribution of experimental
factors (number of cells scored; post-exposure time; scoring
method; temperature; donor; laboratory; sample type) on the
dose estimates. No significant effect was seen for the number
of cells scored (p¼ 0.964), post-exposure time (p¼ 0.143),
scoring method (p¼ 0.873) and temperature during transit
(p¼ 0.057). A significant difference was observed, however,
between the donors (p¼ 0.008), laboratories (p< 0.001) and
sample type (p< 0.001). Pairwise comparisons demonstrated
that the difference between the donors was due to a vari-
ation between donors 2 and 4 (p¼ 0.026). Donor 2 was used
at the 24 h post exposure time-point and donor 4 at 4 h.
When the data for the 24 h blood samples, which were prob-
lematic to separate, stain and score, were excluded from the
analysis no significant effect of donor was seen (p¼ 0.109).
The inter-laboratory difference was due to the variation
between lab 7 and all the other laboratories (p< 0.001). Post-
hoc testing of sample type revealed that there was no signifi-
cant difference between blood and lymphocytes at 4 h post
irradiation (p¼ 0.999), but there was a significant difference
between the sample types at 24 h (p< 0.001). Average dose
estimates across all laboratories for both the reference and
the unknown samples correlated well with the true dose, as
shown in Figure 1, although the 24 h blood estimates had to
be omitted due to the technical difficulties encountered with
these samples. ANOVA and pairwise analysis revealed signifi-
cant differences between the doses (p 0.006), except for
2 and 2.5Gy (p¼ 0.253).
The dose estimates from all the laboratories were then
used to assign the unknown samples to triage categories of
either (1) low exposure <1Gy; (2) medium exposure 1–2Gy,
or (2) high exposure >2Gy. The triage categories used here
were those chosen for the MULTIBIODOSE project and imple-
mented in the MULTIBIODOSE emergency triage categoriza-
tion software (Jaworska et al. 2015). Table 2 shows the triage
categories for the foci-based dose estimates of coded blood
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Figure 1. Average gamma-H2AX-based dose estimates versus the true doses for blood and lymphocyte ex vivo incubated samples; excluding 24-h blood samples.
Error bars show the standard deviation between 5 and 7 (blood) and 11–14 (lymphocyte) measurements for each sample taken from Table 2. The line is not a fit
but indicates the ideal 1:1 relationship.
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and lymphocyte samples for 50 cells scored manually and
200 cells assessed automatically.
Discussion
The calibration curves used to convert foci yields to dose
were prepared during the MULTIBIODOSE or RENEB proj-
ects. Each laboratory constructed their curves as described
in Barnard et al. 2015. In brief, separated lymphocytes
were homogeneously exposed to 0, 1, 2, 3 and 4Gy of
Co60 gamma-rays and then held at 37 C for 4 h and 24 h.
As expected from previous work (Rothkamm et al. 2013b;
Barnard et al. 2015), the 4 h and 24 h calibration curves in
Table 1 show a good fit to the linear dose response
although some individual data showed a degree of satur-
ation between 3 and 4Gy. The Dose Estimate software,
used to fit the dose response curves, gives p-values, based
on the z-test, for each of the calibration coefficients and
these were always found to be satisfactory. The observed
foci numbers varied between laboratories, despite using a
standard protocol, because small variations in sample han-
dling and processing, as well as the reagents used, can
affect the staining and subsequent scoring of foci
(Rothkamm & Horn 2009), so no common calibration curve
can be used by all the laboratories. The inclusion of refer-
ence samples also aimed to control for any variation in
staining between the day of the inter-comparison and set-
ting up the calibration curves in each laboratory, as sug-
gested by Rothkamm et al. (2013b). In addition, the
calibration curves demonstrate the significant effect of
post-exposure time on foci loss, with the average foci
yields at 4 h approximately two times higher than at 24 h.
Therefore, when using foci numbers to convert to a dose
estimate in a real event, it will be important to know the
exact time of irradiation so that an appropriate calibration
curve can be used (Roch-Lefevre et al. 2010; Beels et al.
2010).
The present inter-comparison was not conducted in real
time; however, all laboratories reported their results within
the deadline set by the coordinating laboratory. Timed inter-
comparisons have been described by Rothkamm et al.
(2013a) and Ainsbury et al. (2014) with triage dose estimates,
based on foci counts in 50 cells, reported within 7 h (10 sam-
ples) and 3 h (8 samples), respectively. With a more rapid
processing technique and scoring just 20 cells it may be pos-
sible to produce dose estimates for 96 samples in 7–11 h
(Moquet et al. 2014). Past experience (Rothkamm et al.
2013a; Ainsbury et al. 2014) and the first inter-comparison
(Barnard et al. 2015) have shown that for rapid triage pur-
poses, i.e. detection of moderate to high doses, manual scor-
ing of 50 cells or 200 cells scored automatically, is fully
sufficient and even scoring 20 cells manually or 50 automat-
ically, may be sufficiently accurate in a triage setting. The
present inter-comparison has confirmed that scoring such
low numbers of cells per sample is possible without drastic-
ally changing the dose estimate. The number of cells scored
can have a huge impact on the precision of the dose esti-
mate where an assay is robust but events scarce, e.g. the
dicentric assay (Romm et al. 2014). However, this is much
less of an issue for the gamma-H2AX assay where, in com-
parison, there are many events (foci) per cell and many other
factors contributing to dose uncertainty (Rothkamm & Horn
2009; Rothkamm et al. 2015). In addition, no significant effect
of post-exposure time on the dose estimate was seen, as
found in the first inter-comparison. In the first exercise man-
ual and automatic scoring had produced significantly differ-
ent results (Barnard et al. 2015), but this was not the case in
the second exercise.
The purpose of triage biodosimetry is to rapidly esti-
mate dose and although this initial estimation may not be
very accurate the aim is to place a casualty into the
Table 2. Reported foci-based dose estimates ± standard error obtained by the laboratories for the coded blood and lymphocyte samples shipped
from lab1 to the participants following 60Co gamma irradiation and 4-/24-h ex vivo incubation at 37 C. Triage categories of <1 Gy, 1–2 Gy and
>2 Gy are highlighted in the table in white, light grey and dark grey, respectively.
Dose (Gy)
0.5 2.5
Blood Lymphocytes Blood Lymphocytes
Cells scored manually 50 50 50 50
1-4h 0.86 ± 0.21 1.58 ± 0.22 2.39 ± 0.24 1.42 ± 0.22
3-4h 0.81 ± 0.33 0.93 ± 0.33 2.16 ± 0.35 2.32 ± 0.36
4-4h * 0.76 ± 0.16 * 2.77 ± 0.21
5-4h 1.17 ± 0.30 1.17 ± 0.30 2.07 ± 0.31 2.05 ± 0.31
6-4h 0.45 ± 0.07 0.69 ± 0.07 2.58 ± 0.17 2.14 ± 0.12
7-4h * 0.00 ± 0.12 * 1.16 ± 0.29
8-4h 0.64 ± 0.28 0.77 ± 0.34 2.69 ± 0.32 2.10 ± 0.36
1-24h 0.30 ± 0.11 1.82 ± 0.23 0.60 ± 0.11 2.94 ± 0.28
3-24h 0.13 ± 0.09 1.20 ± 0.19 0.44 ± 0.07 1.65 ± 0.21
4-24h * 0.75 ± 0.13 * 3.46 ± 0.24
6-24h * 1.00 ± 0.19 * 3.51 ± 0.44
Cells scored automatically 200 200 200 200
6-4h 0.63 ± 0.09 1.35 ± 0.19 1.92 ± 0.18 2.13 ± 0.26
7-4h * 0.00 ± 0.24 * 0.39 ± 0.25
8-4h 1.00 ± 0.86 0.69 ± 0.09 2.37 ± 0.12 2.86 ± 0.12
Samples were fixed, immunostained and scored manually and/or automatically with MetacyteVR . Dose estimates ± standard error are shown based
on manual scoring of 50 cells or automated scoring of 200 cells. Shading reflects triage categories of <1 Gy (white), 1–2 Gy (light grey) and
>2 Gy (dark grey) based on the dose estimate alone.
*No result
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correct triage category (IAEA 2011). As Table 2 shows,
manual scoring of the 4 h blood samples achieved the
most accurate assignment of triage category for both the
0.5 Gy samples (4 out of 5) and the 2.5 Gy samples (5 out
of 5). The 4 h lymphocyte samples also provided good tri-
age categorization with five out of seven samples correctly
assigned at each dose. Automated scoring of the 4 h sam-
ples for both blood and lymphocytes showed greater devi-
ation than the manual scoring; with two out of four blood
and four out of six lymphocytes samples were correctly
assigned to a triage category at both doses. Dose esti-
mates for the 24 h blood samples irradiated with 0.5 Gy
gave good triage categorization (2 out of 2), but the
2.5 Gy samples were poor (0 out of 2). The reverse was
seen with the 24 h lymphocyte samples, where one out of
four of the 0.5 Gy samples were correctly categorized com-
pared to three out of four at 2.5 Gy.
It is important to note that in total only three of the 46
blind samples, i.e. <7% were miscategorized such that this
could have had an adverse effect on the clinical manage-
ment of a radiation casualty. The other 12 miscategoriztions
merely placed the samples one category up or down into
the medium exposure group, which would have no clinical
implications as both high and the medium exposure groups
would have been double-checked using the ‘gold standard’
cytogenetic assays for follow-up biodosimetry. Of the three
2.5 Gy samples that fell into the <1Gy triage category, which
the z-score analysis had also shown to give unsatisfactory
dose estimates, one was a 4 h lymphocyte sample scored
automatically in lab 7. The results of the 2Gy reference sam-
ple from lab 7 also showed very low foci numbers compared
to that expected from their calibration curve. In addition, the
foci numbers observed with manual scoring were higher
than those found with automated scoring for all samples
from this lab. Lab 7 is not as experienced in using automatic
scoring as partners 6 and 8 and may require more training in
using an automated system. The other two samples in the
<1Gy triage category came from the 24 h blood (manual
scoring) samples. The need for an ex vivo incubation at 37 C
caused the problem of haemolysis during lymphocyte separ-
ation, which affected the subsequent staining and analysis of
the whole blood samples, especially at the 24 h time-point.
However, in a real event there would be no need to simulate
in vivo repair, so the issue of haemolysis would be much less
of a problem.
The aim of the work reported in this manuscript was to
assess the usefulness of the gamma-H2AX assay for rapid
dose categorization to aid in emergency response. As such,
the assay has been applied according to the standardized
methodologies developed during MULTIBIODOSE and RENEB
(Horn et al. 2011; Rothkamm et al. 2013b; Barnard et al.
2015). To improve dose estimates, however, there are a num-
ber of additional points that will need to be addressed going
forward, before all the influencing factors are fully under-
stood and the assay can be categorized as fully operational
for routine dose estimation. This includes the variability
between individual slides (staining reproducibility) and vari-
ability between images (image/microscope setting reproduci-
bility) (Rothkamm & Horn 2009; Rothkamm et al. 2015).
Conclusions
The aim of the RENEB project has been to establish a sustain-
able European network that can provide rapid triage bio-
dosimetry, using existing biological and retrospective
techniques, in the event of a large scale radiological emer-
gency. Unlike the more established biodosimetry methods,
such as the dicentric and micronucleus techniques, the
gamma-H2AX assay is a more recent method for radiation
dose assessment. The RENEB partners were able to categorize
the majority of the samples in such a way that there would
be no adverse effect on the clinical management of a radi-
ation casualty. Overall, the results of the second RENEB inter-
comparison suggest that the gamma-H2AX assay could be a
very useful triage tool following a recent acute radiation
exposure. Severely exposed individuals within a large cohort
can be identified in a very short space of time and then
given priority for further follow-up, including more accurate
traditional chromosome dosimetry. Furthermore, with stand-
ardization of methodology, application across a network of
laboratories can be very successful. However, it is recom-
mended that any new partner wishing to join the network
must have laboratory-specific calibration curves and a pro-
gram of continuous training/quality assurance, e.g. inter-
comparisons, is maintained for existing and new partners.
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